Vickor

Wuhan Vickor Medical Technology Co., Ltd. was established on July 18, 2018, located in the core area of the Wuhan section of the China (Hubei) Pilot Free Trade Zone. Its main business scope includes the research and development, technical services, production, and sales of Class III medical devices. It is an innovative enterprise dedicated to the field of minimally invasive interventional treatment for cardiovascular and cerebrovascular diseases, especially structural heart disease.The company's founders, R&D, and management team are composed of experts in structural heart disease intervention, cardiac surgery, metal materials, braided device production and R&D, and Class III medical device registration, forming a strong integration of medical, research, and enterprise cooperation. The company has applied for 35 patents, including 29 invention patents, 5 utility model patents, and 1 PCT patent, with strategic focus on the field of interventional treatment for structural heart disease. Its products and technologies remain at the forefront of international developments.The company owns a 300-square-meter office building and shares a 10,000-square-meter GMP factory and a Class 10,000 cleanroom within an industrial incubation platform. It has established a complete production line for a series of nickel-titanium alloy braided products and various testing equipment, forming standardized production processes. The company has won numerous awards, including the "Most Investment Value Award" at the 5th HuaChuang Cup; the champion of the biotech category at the 2018 HuaChuang Cup Innovation and Entrepreneurship Competition; the Excellence Award in the finals of the Northern Region of the 2018 China Medical Device Innovation Competition; the second prize and Most Popular Award at the finals of the "Yellow Crane Cup · 2018 China Optics Valley 3551 International Entrepreneurship Competition"; third prize at the 2019 China Medical Device Innovation and Entrepreneurship Competition; first prize at the First "Bairuike Guojian Cup" Direct to Cleveland International Medical Innovation and Entrepreneurship Competition; inclusion in the 12th batch of the "3551 Optics Valley Talent Plan" of Hubei Province; the Excellent Enterprise Award at the 8th China Innovation and Entrepreneurship Competition; recognition as a "Gazelle Enterprise" in the East Lake High-Tech Development Zone in 2019; second prize and "Top Ten Entrepreneurship Award" at the 2019 Hubei Province "Worker's Cup" Employee Innovation and Entrepreneurship Competition; first prize at the 6th "HuaChuang Cup" Entrepreneurship Competition; one of the Top Ten Entrepreneurs at the 3rd "Golden Nest Award" in Shaanxi Province in 2019; a "New Fourth Army" enterprise in the East Lake High-Tech Development Zone; a leading enterprise in Hubei Province's "Technology Little Giant" program; recipient of the Hubei May Day Labor Medal and named a "Guanggu Star Entrepreneur" enterprise in 2019; recognized again as a "Gazelle Enterprise" in the East Lake High-Tech Development Zone in 2020; designated as a "National High-Tech Enterprise" in 2020; and winner of the third prize in the finals of the 9th China Innovation and Entrepreneurship Competition (Hubei Region) in 2020.